Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT06270706
Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · Spain, United States · 27 sites
Registry update: 12 Nov 2026
2024-513006-61-00
Recruiting
An open-label, multicentre, rollover study to evaluate safety and antineoplastic activity of OATD-02 in patients with selected advances and/or metastatic solid tumours who completed the first-in-human study OATD-02-C-01
Phase 1 · Poland · 3 sites
Registry update: 19 Feb 2026
NCT06572501
Recruiting
Robot-assisted Laparoscopic Partial Nephrectomy Via the Extraperitoneal Approach in the Prone Position Versus the Lateral Position
Not applicable · China · 1 site
Registry update: 27 Aug 2024
NCT05287945
Recruiting
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Phase 1/2 · Spain, France, Portugal, Sweden, United States · 10 sites
Registry update: 1 Oct 2026
NCT05944237
Recruiting
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2 · United Kingdom · 6 sites
Registry update: 1 Oct 2026
NCT06076538
Recruiting
PET/MR for Characterization of Renal Masses (RMs)
Not applicable · United States · 2 sites
Registry update: 4 Aug 2026
NCT05985161
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Phase 2 · United States · 16 sites
Registry update: 23 Oct 2026
NCT05837767
Recruiting
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Not applicable · United States · 7 sites
Registry update: 2 Sept 2026
NCT05127824
Recruiting
Autologous Dendritic Cell Vaccine in Kidney Cancer
Phase 2 · United States · 1 site
Registry update: 7 Jul 2026
NCT05753839
Recruiting
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
Not applicable · South Korea · 3 sites
Registry update: 22 Jun 2023
NCT05663710
Recruiting
Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC
Phase 1/2 · United States · 1 site
Registry update: 3 Nov 2026
NCT06194669
Recruiting
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
Not applicable · Italy · 1 site
Registry update: 10 Jan 2024
NCT04969315
Recruiting
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Phase 1/2 · United States · 2 sites
Registry update: 15 Sept 2026
NCT05805436
Recruiting
Preop Laxatives in Robotic Urologic Surgery
Phase 4 · United States · 1 site
Registry update: 30 May 2025
NCT05824975
Recruiting
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Phase 1/2 · South Korea, United States · 10 sites
Registry update: 25 Nov 2024
NCT05888532
Recruiting
64Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/2 · United States · 1 site
Registry update: 17 Mar 2026
NCT05868174
Recruiting
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Phase 1 · Australia · 5 sites
Registry update: 1 May 2024
NCT05890781
Recruiting
Engineering Immune Organoids to Study Pediatric Cancer
Not applicable · France · 2 sites
Registry update: 9 Feb 2026
NCT05733715
Recruiting
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Early phase 1 · United States · 1 site
Registry update: 13 Aug 2026
NCT05738694
Recruiting
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Phase 3 · China · 8 sites
Registry update: 17 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.